Peripheral nerve injuries, often caused by traumatic events such as car accidents, falls or battlefield injuries, can leave patients with long-term weakness, numbness or loss of function. Despite ...

Key takeaways• Researchers at The Ohio State University College of Medicine and College of Engineering developed a novel gene ...

RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...

Researchers introduced an automated solution that reduces variability and manual intervention in cell therapy workflows, ...

At a first meeting on pediatric gene and cell therapy trials, participants discussed when enrolling children before adults is ethical and when to wait.

University of Virginia School of Medicine scientists have used a next-generation form of gene editing to fix the underlying cause of a severe form of epilepsy in lab mice.

Using base editing, researchers targeted a genetic mutation linked to severe epilepsy. The approach reduced seizures and ...

Right ventricular (RV) remodeling and dysfunction are serious cardiovascular consequences due to prolonged hypoxic exposure, ...

Cancer treatments can raise risk of therapy-related acute myeloid leukemia over time. A Japan study shows rising cases, stressing long-term monitoring while noting treatment benefits still outweigh ...

Despite clear clinical guidelines, many Parkinson's disease patients in India are being referred too late for Deep Brain ...

Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to the ...

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies for hard-to-treat solid tumors, today announced the appointment of Lisa ...